Event organised by the Westminster Health Forum. Delegates will examine commitments outlined in the Confronting antimicrobial resistance: 2024 to 2029 policy paper published in May, as well as priorities for delivering key ambitions set out in the plan.
Areas for discussion include increasing public and health workforce knowledge of AMR, reducing antibiotic use in humans by 5% from the 2019 baseline, and preventing an increase in specified drug resistant human infections from the 2019-20 baseline.
Online
Ask for a Free trial and get access to the latest stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
REQUEST
an initial 10 day temporary access of APM Market Access.
